TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression
TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression
复制标题
TRAF7增强KLF4的泛素降解促进肝细胞癌进展
DOI:
10.1016/j.canlet.2019.11.012
复制
发表时间:
2020-01-01
期刊:
影响因子:
9.7
通讯作者:
Qu, Chunfeng
中科院分区:
文献类型:
--
作者:
He, Huan;Wu, Zhiyuan;Qu, Chunfeng
The tumor necrosis factor receptor-associated factor 7 (TRAF7) is a component of the tumor necrosis factor alpha (TNF-alpha)/nuclear factor kappa B (NF-kappa B) pathway and is a putative E3-ubiquitin ligase. Based on importance of chronic inflammation in hepatocellular carcinoma (HCC), we investigated the biological effects and the molecular mechanisms of deregulated TRAF7 signaling in HCC. Our results showed that high TRAF7 expression in HCC samples was inversely associated with Kruppel-like factor 4 (KLF4) expression and the prognosis of HCC patients. TRAF7 could degrade KLF4 protein through ubiquitin by interacting with its N-terminus. The up-regulation of TRAF7 promoted HCC cell migration and invasion in vivo and in vitro, and TRAF7 knockdown had the opposite effects. Restoration of KLF4 abrogated the motility promotion induced by TRAF7. TRAF7 promotes HCC cell motility through inducing KLF4 protein turnover.